Zhejiang Huahai Pharmaceutical Co., Ltd. Class ASSE: 600521

"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026

Aug 27, 2026 · Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Huahai Pharmaceutical Co., Ltd. Class A

"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Subsidiary Passing the Drug GMP Compliance InspectionAug 20
"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on the Proposed Selection of the Company's Products in the 12th Batch of National Centralized Drug ProcurementAug 3
"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on the Signing of the Four-Party Supervision Agreement for Raised FundsJul 30

All Zhejiang Huahai Pharmaceutical Co., Ltd. Class A news releases